Genor Biopharma Files Director List with HKEX

Reuters2025-12-30

Genor Biopharma Files Director List with HKEX

Genor Biopharma Holdings Ltd., now known as Edding Genor Group Holdings Limited, has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The board consists of Executive Directors Mr. Ni Xin and Ms. Zhai Jing; Non-executive Directors Dr. David Guowei Wang and Mr. Yu Tieming; and Independent Non-executive Directors Dr. Xu Qing, Mr. Chen Wen, and Ms. Zheng Jingjing. Committee memberships are as follows: The Audit Committee is chaired by Ms. Zheng Jingjing, with Mr. Yu Tieming and Dr. Xu Qing as members. The Compensation Committee is chaired by Dr. Xu Qing, joined by Dr. David Guowei Wang and Mr. Chen Wen as members. The Nomination Committee is chaired by Mr. Ni Xin, with Dr. Xu Qing and Ms. Zheng Jingjing as members.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genor Biopharma Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251230-11969926), on December 29, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2595213755?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-30 06:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2595213755","market":"fut","top_or_hot":-1,"title":"Genor Biopharma Files Director List with HKEX","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Genor Biopharma Files Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Genor Biopharma Holdings Ltd., now known as Edding Genor Group Holdings Limited, has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The board consists of Executive Directors Mr. Ni Xin and Ms. Zhai Jing; Non-executive Directors Dr. David Guowei Wang and Mr. Yu Tieming; and Independent Non-executive Directors Dr. Xu Qing, Mr. Chen Wen, and Ms. Zheng Jingjing. Committee memberships are as follows: The Audit Committee is chaired by Ms. Zheng Jingjing, with Mr. Yu Tieming and Dr. Xu Qing as members. The Compensation Committee is chaired by Dr. Xu Qing, joined by Dr. David Guowei Wang and Mr. Chen Wen as members. The Nomination Committee is chaired by Mr. Ni Xin, with Dr. Xu Qing and Ms. Zheng Jingjing as members.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genor Biopharma Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251230-11969926), on December 29, 2025, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genor Biopharma Files Director List with HKEX</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenor Biopharma Files Director List with HKEX\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-30 06:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Genor Biopharma Files Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Genor Biopharma Holdings Ltd., now known as Edding Genor Group Holdings Limited, has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The board consists of Executive Directors Mr. Ni Xin and Ms. Zhai Jing; Non-executive Directors Dr. David Guowei Wang and Mr. Yu Tieming; and Independent Non-executive Directors Dr. Xu Qing, Mr. Chen Wen, and Ms. Zheng Jingjing. Committee memberships are as follows: The Audit Committee is chaired by Ms. Zheng Jingjing, with Mr. Yu Tieming and Dr. Xu Qing as members. The Compensation Committee is chaired by Dr. Xu Qing, joined by Dr. David Guowei Wang and Mr. Chen Wen as members. The Nomination Committee is chaired by Mr. Ni Xin, with Dr. Xu Qing and Ms. Zheng Jingjing as members.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genor Biopharma Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251230-11969926), on December 29, 2025, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06998","symbol_name":"嘉和生物","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL9rw5pj:1","article_id":"2595213755","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2595213755","pubTimestamp":1767048169,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Genor Biopharma Holdings Ltd., now known as Edding Genor Group Holdings Limited, has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The board consists of Executive Directors Mr. Ni Xin and Ms. Zhai Jing; Non-executive Directors Dr. David Guowei Wang and Mr. Yu Tieming; and Independent Non-executive Directors Dr. Xu Qing, Mr. Chen Wen, and Ms. Zheng Jingjing. Committee memberships are as follows: The Audit Committee is chaired by Ms. Zheng Jingjing, with Mr. Yu Tieming and Dr. Xu Qing as members. The Compensation Committee is chaired by Dr. Xu Qing, joined by Dr. David Guowei Wang and Mr. Chen Wen as members. The Nomination Committee is chaired by Mr. Ni Xin, with Dr. Xu Qing and Ms. Zheng Jingjing as members.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06998":"嘉和生物","BK1574":"生物医药B类股","BK1161":"生物科技","BK1583":"高瓴概念"},"translate_title":"嘉和生物制药向港交所提交董事名单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06998":0.9},"content_text":"Genor Biopharma Files Director List with HKEX\n    \n\n        Genor Biopharma Holdings Ltd., now known as Edding Genor Group Holdings Limited, has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The board consists of Executive Directors Mr. Ni Xin and Ms. Zhai Jing; Non-executive Directors Dr. David Guowei Wang and Mr. Yu Tieming; and Independent Non-executive Directors Dr. Xu Qing, Mr. Chen Wen, and Ms. Zheng Jingjing. Committee memberships are as follows: The Audit Committee is chaired by Ms. Zheng Jingjing, with Mr. Yu Tieming and Dr. Xu Qing as members. The Compensation Committee is chaired by Dr. Xu Qing, joined by Dr. David Guowei Wang and Mr. Chen Wen as members. The Nomination Committee is chaired by Mr. Ni Xin, with Dr. Xu Qing and Ms. Zheng Jingjing as members.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genor Biopharma Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251230-11969926), on December 29, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2595213755","isCrawlerRequest":true}